Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ’s Imfinzi scores FDA breakthrough therapy designation in wake of major trial failure

pharmafileAugust 01, 2017

Tag: AZ , cancer

PharmaSources Customer Service